Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Robohogs who wrote (9444)	5/16/2006 12:16:56 AM
From: Iamarangerboy	Read Replies (2) \| Respond to of 10280

true, but there may be a recent uptick.... the next couple of weeks will be interesting to see if the trend continues.... other notes is that L still has a slight lead on A-CR in both TRx and NRx. A-CR grew approximately 8% last week, as did L, but A grew approximately 6%, for a slight increase % for L relative to A. Also note that this data really reflects data just prior to the Kennedy accident. And although most docs believe that the incidence of sleep driving is very low, docs are overall a cautious breed, and might tend to a drug with no risk as opposed to low risk. In addition, the added sales force will only come into play in the next few months, as the effectiveness of a sales force tends to increase with time, as relationships are developed.... again, I am always the optimist....